Drug Trial Radar · NCT06148025
Antibiotics and Vaccine Immune Responses Study
Last checked: Nov 19, 2026Latest source record: Sep 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
348
Planned (sponsor's estimate)
Start
Nov 23, 2023
Primary completion
Oct 1, 2027
Study completion Oct 1, 2028
Sponsor
- Lead sponsor
- South Australian Health and Medical Research InstituteAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Royal Adelaide Hospital; Flinders University; University of Sydney; Telethon Kids Institute; Centenary Institute
- First posted
- Nov 28, 2023
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Basic science
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 35 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to examine immune responses to the BCG vaccine in healthy adults who have, or who have not, taken antibiotics to deplete their gut bacteria prior to vaccination. The main question it aims to answer is: does depletion of the gut microbiota lead to impaired BCG-induced protection against specific and non-specific to challenges to the immune system?
Conditions
- Vaccine Response Impaired
Interventions
BCG vaccineBiological
0.1ml injected intradermally over the distal insertion of the deltoid muscle onto the humerus
Yellow Fever vaccineBiological
0.5ml injected subcutaneously
Vancomycin Oral CapsuleDrug
500mg every 6 hours for 3 days
Neomycin Oral ProductDrug
1000mg every 6 hours for 3 days
Metoclopramide (Maxolon)Drug
10mg every 8 hours
Loperamide HClDrug
2mg tablets/capsules: 2 tablets/capsules initially, followed by 1 tablet after each loose motion, to a maximum of 8 tablets/capsules per day
Primary outcomes
What the sponsor says the trial is designed to measure.
- Sub-study 1 BCG re-challengeTime frame: 2 weeks post BCG challenge
- Sub-study 2 Yellow Fever vaccineTime frame: 3, 5, 7 days post YFV challenge
Locations
1 site in 1 country. Site status is shown where the registry gives one.
South Australian Health and Medical Research Institute
Adelaide, South Australia, Australia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.